Olema Oncology Company
.jpg)
Olema Oncology is a preclinical biotechnology company that develops new drugs for the treatment and prevention of breast cancer.
Investors
Total Funding:
$145,054,922
Headquarters:
San Francisco, California, United States
Funding Status:
IPO
Employee Number:
11-50
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series C
Last Funding Date:
2020-10-01
Investors Number:
16
Founded Date:
01-01-2007
Industry:
General Health Care